한글목차

세포 유리 DNA(cfDNA) 키트 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 18억 달러에서 2026년에는 20억 2,000만 달러로, CAGR 12.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 액체생검의 채택 확대, 암 진단의 성장, 산전 검사 증가, PCR 및 차세대 염기서열 분석(NGS) 기술 개발, 연구소 증가에 기인하는 것으로 보입니다.

무세포 DNA(cfDNA) 키트 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 32억 달러에 달하며, CAGR은 12.2%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 cfDNA 키트의 기술 혁신, 비침습적 진단에 대한 관심 증가, 분석의 AI 통합, 신흥 시장에서의 분자 검사 확대, 암 바이오마커 연구개발(R&D) 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향에는 고감도 DNA 분리, 시료 준비 자동화, 차세대 염기서열 분석(NGS) 플랫폼과의 통합, 신속한 DNA 추출, 표준화된 cfDNA 키트 등이 포함됩니다.

유전성 질환의 유병률 증가는 향후 수년간 세포 유리 DNA(cfDNA) 키트 시장의 성장을 촉진할 것으로 예측됩니다. 유전성 질환은 하나 이상의 유전자 돌연변이 또는 염색체 이상에 의해 발생하는 개인의 DNA 변화에 기인하는 병입니다. 이러한 질병 발생률 증가는 주로 생활습관의 변화, 오염, 부적절한 식습관 등 환경적 요인에 기인하며, 이는 유전자 변이를 유발하거나 유전성 질환을 악화시킬 수 있습니다. 무세포 DNA(cfDNA) 키트는 혈액 및 기타 체액에 존재하는 DNA 단편을 분석하여 유전적 이상을 조기에 비침습적으로 검출할 수 있습니다. 이 기술은 신속한 진단을 촉진하고 의료진이 정확한 치료 결정을 내릴 수 있도록 돕습니다. 예를 들어 미국 질병예방통제센터(CDC)는 2024년 11월, 미국에서는 신생아 33명 중 1명이 선천성 기형을 가지고 태어나는데, 그 중 상당수가 유전적 요인과 관련이 있다고 보고했습니다. 그 결과, 유전성 질환 증가 추세는 cfDNA 키트에 대한 수요를 촉진하고 있습니다.

cfDNA 키트 시장의 주요 기업은 디지털 중합효소 연쇄반응(PCR)에 기반한 절대정량법을 채택한 혁신적인 제품 개발에 주력하여 cfDNA 분석의 민감도와 정확도를 향상시키고 있습니다. 디지털 PCR에 의한 절대정량법은 저빈도 유전자 변이를 높은 일관성으로 정밀하게 검출할 수 있으며, 암 진단, 산전검사, 이식 거부반응 모니터링과 같은 중요한 용도에 적합합니다. 예를 들어 2024년 6월 헝가리 소재 분자진단 기업 오믹슨(Omixon)은 이식 후 공여자 유래 세포 유리 DNA(dd-cfDNA)를 모니터링하는 연구용 키트 'HoloGRAFT ONE'을 발표했습니다. 본 키트는 독자적인 유전자 마커와 디지털 PCR 기술을 활용하여 기증자 DNA와 수혜자 DNA를 식별합니다. 카피 수 변이(CNV)를 통해 dd-cfDNA의 절대량과 상대량을 측정합니다. 이 혁신적인 검사의 목적은 이식 거부반응을 조기에 발견하고, 환자 모니터링을 개선하며, 임상의에게 정확한 cfDNA 데이터를 제공함으로써 이식 후 맞춤형 의료를 지원하는 것입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cell-free DNA (cfDNA) kits are laboratory tools designed to isolate and analyze fragmented DNA circulating in blood or other body fluids. They support non-invasive genetic testing by providing high-quality DNA for applications such as prenatal screening, cancer diagnostics, and transplant monitoring. These kits simplify sample preparation and enhance accuracy in downstream molecular analysis.

The primary product types in the cell-free DNA (cfDNA) kits market include plasma cfDNA kits, serum cfDNA kits, urine cfDNA kits, and others. Plasma cfDNA kits are designed to isolate and analyze DNA fragments circulating in plasma, the liquid component of blood. Key technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, and digital PCR. Major applications encompass cancer diagnostics, prenatal testing, transplant rejection monitoring, and non-invasive disease detection. Distribution channels consist of direct sales, retail pharmacies, online platforms, and distributors, while end users include hospitals, research laboratories, diagnostic laboratories, and academic institutions.

Tariffs are impacting the cfDNA kits market by raising costs for imported reagents and extraction kits, affecting hospitals, research laboratories, and diagnostic centers. Regions like north america and europe, which import most cfDNA kits, are most affected. Positive impacts include incentivizing local production of high-quality kits and encouraging innovation in rapid, standardized extraction solutions.

The cell-free dna (cfdna) kits market research report is one of a series of new reports from The Business Research Company that provides cell-free dna (cfdna) kits market statistics, including cell-free dna (cfdna) kits industry global market size, regional shares, competitors with a cell-free dna (cfdna) kits market share, detailed cell-free dna (cfdna) kits market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free dna (cfdna) kits industry. This cell-free dna (cfdna) kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free dna (cfdna) kits market size has grown rapidly in recent years. It will grow from $1.8 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to rising adoption of liquid biopsy, growth in cancer diagnostics, increasing prenatal testing, development of PCR and NGS technologies, growth in research laboratories.

The cell-free dna (cfdna) kits market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological innovations in cfDNA kits, increasing focus on non-invasive diagnostics, AI integration in analysis, expansion of molecular testing in emerging markets, increased R&D in cancer biomarkers. Major trends in the forecast period include high-sensitivity dna isolation, automation of sample preparation, integration with ngs platforms, rapid dna extraction, standardized cfdna kits.

The increasing prevalence of genetic disorders is expected to drive the growth of the cell-free DNA (cfDNA) kits market in the coming years. Genetic disorders are medical conditions caused by alterations in a person's DNA, which can result from mutations in one or more genes, or chromosomal abnormalities. The rising occurrence of these disorders is largely due to lifestyle changes and environmental factors such as pollution and poor diet, which can either cause genetic mutations or worsen inherited conditions. Cell-free DNA (cfDNA) kits enable early, non-invasive detection of genetic abnormalities by analyzing DNA fragments present in blood or other body fluids. This technology facilitates quicker diagnoses and allows healthcare providers to make accurate treatment decisions. For example, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported in November 2024 that about 1 in every 33 newborns in the U.S. is born with a birth defect, many of which are genetically related. As a result, the increasing prevalence of genetic disorders is fueling demand for cfDNA kits.

Leading companies in the cfDNA kits market are concentrating on developing innovative products that use digital polymerase chain reaction (PCR)-based absolute quantification to enhance the sensitivity and accuracy of cfDNA analysis. Digital PCR-based absolute quantification allows for the precise detection of low-frequency genetic variants with improved consistency, making it suitable for critical applications such as cancer diagnostics, prenatal testing, and monitoring transplant rejection. For example, in June 2024, Omixon, a molecular diagnostics company based in Hungary, introduced HoloGRAFT ONE, a research-use-only kit designed to monitor donor-derived cell-free DNA (dd-cfDNA) post-transplant. This kit utilizes proprietary genetic markers and digital PCR to differentiate donor DNA from the recipient's DNA, measuring both absolute and relative amounts of dd-cfDNA through copy-number variants. The goal of this innovative test is to enable the early detection of transplant rejection, improve patient monitoring, and support personalized post-transplant care by providing clinicians with precise cfDNA data.

In November 2025, Natera Inc., a US-based genetic testing and diagnostics firm, acquired specific reproductive health assets from Invitae for an undisclosed sum. Through this acquisition, Natera intends to broaden its molecular diagnostic offerings and expand its customer reach by incorporating Invitae's non-invasive prenatal screening and carrier screening operations, allowing greater access to personalized genetic testing and diagnostic services. Invitae Corporation is a US-based medical genetics company focused on cell-free DNA (cfDNA) testing kits for non-invasive prenatal testing and oncology purposes.

Major companies operating in the cell-free dna (cfdna) kits market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc., Paragon Genomics Inc., Suzhou Beaver Biomedical Engineering.

North America was the largest region in the cell-free DNA (cfDNA) kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell-free dna (cfdna) kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) kits market consists of revenues earned by entities by providing services such as purification services, bulk services, quality control (QC) services, data integration services, and custom biomarker discovery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) kits market also includes sales of plasma separation consumables, liquid biopsy assay kits, serum preparation kits, concentration kits, and bisulfite conversion and methylation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell-free dna (cfdna) kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Plasma Cell-Free DNA (Cfdna) Kits; Serum Cell-Free DNA (Cfdna) Kits; Urine Cell-Free DNA (Cfdna) Kits; Other Product Types
• 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Technology; Digital Polymerase Chain Reaction(PCR)
• 3) By Application: Cancer Diagnostics; Prenatal Testing; Transplant Rejection Monitoring; Non-Invasive Disease Detection
• 4) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Sales; Distributors
• 5) By End User: Hospitals; Research Laboratories; Diagnostic Laboratories; Academic Institutions
• Subsegments:
• 1) By Plasma Cell-Free DNA Kits: Single-Stranded DNA Kits; Double-Stranded DNA Kits; High-Sensitivity DNA Kits; Rapid Extraction DNA Kits
• 2) By Serum Cell-Free DNA Kits: Low-Volume DNA Kits; High-Yield DNA Kits; Automated DNA Kits; Manual Extraction DNA Kits
• 3) By Urine Cell-Free DNA Kits: Early Detection DNA Kits; Concentration DNA Kits; High-Purity DNA Kits; Long-Term Stability DNA Kits
• 4) By Other Product Types: Saliva DNA Kits; Cerebrospinal Fluid DNA Kits; Amniotic Fluid DNA Kits; Tissue-Derived DNA Kits
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Bioneer Corporation; Streck Inc.; Freenome Holdings Inc.; GRAIL Inc.; Zymo Research Corporation; Geneseeq Technology Inc; Covaris LLC; Active Motif Inc.; Norgen Biotek Corp; AMSBIO LLC; EpiGentek Group Inc.; Paragon Genomics Inc.; Suzhou Beaver Biomedical Engineering.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cell-Free DNA (cfDNA) Kits Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cell-Free DNA (cfDNA) Kits Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cell-Free DNA (cfDNA) Kits Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cell-Free DNA (cfDNA) Kits Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 High-Sensitivity Dna Isolation
  • 4.2.2 Automation Of Sample Preparation
  • 4.2.3 Integration With Ngs Platforms
  • 4.2.4 Rapid Dna Extraction
  • 4.2.5 Standardized Cfdna Kits

5. Cell-Free DNA (cfDNA) Kits Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Research Laboratories
• 5.3 Diagnostic Laboratories
• 5.4 Academic Institutions
• 5.5 Pharmaceutical Companies

6. Cell-Free DNA (cfDNA) Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell-Free DNA (cfDNA) Kits Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cell-Free DNA (cfDNA) Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cell-Free DNA (cfDNA) Kits Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cell-Free DNA (cfDNA) Kits Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cell-Free DNA (cfDNA) Kits Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell-Free DNA (cfDNA) Kits Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell-Free DNA (cfDNA) Kits Market Segmentation

• 9.1. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Plasma Cell-Free DNA (Cfdna) Kits, Serum Cell-Free DNA (Cfdna) Kits, Urine Cell-Free DNA (Cfdna) Kits, Other Product Types
• 9.2. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Technology, Digital Polymerase Chain Reaction(PCR)
• 9.3. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer Diagnostics, Prenatal Testing, Transplant Rejection Monitoring, Non-Invasive Disease Detection
• 9.4. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Direct Sales, Retail Pharmacies, Online Sales, Distributors
• 9.5. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Research Laboratories, Diagnostic Laboratories, Academic Institutions
• 9.6. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Plasma Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Stranded DNA Kits, Double-Stranded DNA Kits, High-Sensitivity DNA Kits, Rapid Extraction DNA Kits
• 9.7. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Serum Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Low-Volume DNA Kits, High-Yield DNA Kits, Automated DNA Kits, Manual Extraction DNA Kits
• 9.8. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Urine Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Early Detection DNA Kits, Concentration DNA Kits, High-Purity DNA Kits, Long-Term Stability DNA Kits
• 9.9. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Saliva DNA Kits, Cerebrospinal Fluid DNA Kits, Amniotic Fluid DNA Kits, Tissue-Derived DNA Kits

10. Cell-Free DNA (cfDNA) Kits Market Regional And Country Analysis

• 10.1. Global Cell-Free DNA (cfDNA) Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cell-Free DNA (cfDNA) Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market

• 11.1. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell-Free DNA (cfDNA) Kits Market

• 12.1. China Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell-Free DNA (cfDNA) Kits Market

• 13.1. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell-Free DNA (cfDNA) Kits Market

• 14.1. Japan Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell-Free DNA (cfDNA) Kits Market

• 15.1. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell-Free DNA (cfDNA) Kits Market

• 16.1. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell-Free DNA (cfDNA) Kits Market

• 17.1. South Korea Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell-Free DNA (cfDNA) Kits Market

• 18.1. Taiwan Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell-Free DNA (cfDNA) Kits Market

• 19.1. South East Asia Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell-Free DNA (cfDNA) Kits Market

• 20.1. Western Europe Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell-Free DNA (cfDNA) Kits Market

• 21.1. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell-Free DNA (cfDNA) Kits Market

• 22.1. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell-Free DNA (cfDNA) Kits Market

• 23.1. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell-Free DNA (cfDNA) Kits Market

• 24.1. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell-Free DNA (cfDNA) Kits Market

• 25.1. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell-Free DNA (cfDNA) Kits Market

• 26.1. Eastern Europe Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell-Free DNA (cfDNA) Kits Market

• 27.1. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell-Free DNA (cfDNA) Kits Market

• 28.1. North America Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell-Free DNA (cfDNA) Kits Market

• 29.1. USA Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell-Free DNA (cfDNA) Kits Market

• 30.1. Canada Cell-Free DNA (cfDNA) Kits Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell-Free DNA (cfDNA) Kits Market

• 31.1. South America Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell-Free DNA (cfDNA) Kits Market

• 32.1. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell-Free DNA (cfDNA) Kits Market

• 33.1. Middle East Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell-Free DNA (cfDNA) Kits Market

• 34.1. Africa Cell-Free DNA (cfDNA) Kits Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell-Free DNA (cfDNA) Kits Market Regulatory and Investment Landscape

36. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Company Profiles

• 36.1. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cell-Free DNA (cfDNA) Kits Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cell-Free DNA (cfDNA) Kits Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cell-Free DNA (cfDNA) Kits Market Other Major And Innovative Companies

• QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc

38. Global Cell-Free DNA (cfDNA) Kits Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Kits Market

40. Cell-Free DNA (cfDNA) Kits Market High Potential Countries, Segments and Strategies

• 40.1 Cell-Free DNA (cfDNA) Kits Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cell-Free DNA (cfDNA) Kits Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cell-Free DNA (cfDNA) Kits Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer